Study of Nivolumab (BMS-936558) in Combination With Gemcitabine/Cisplatin, Pemetrexed/Cisplatin, Carboplatin/Paclitaxel, Bevacizumab Maintenance, Erlotinib, Ipilimumab or as Monotherapy in Subjects With Stage IIIB/IV Non-small Cell Lung Cancer (NSCLC) (CheckMate 012)
Clinical trial NCT01454102 · COMPLETED
Trial details
- NCT number
- NCT01454102
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-16
- Primary completion
- 2016-07-20
- Enrollment
- 472
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.